2024

• 04

  Selected for Drug Value Evaluation Support Project. Korea Drug Development Fund

• 01

  Application for Phase 1 Clinical Trials (¹⁸F-DMPY2)

2023

• 05

  Selected for the 2023 Clinical Trial-Linked Support Program for Therapeutic Vaccines

• 02

  Completion of Salmonella-based Armed Microbe(SAM) MCB Development

2022

• 10

  MOU Signed by CNCure Biotech, Chonnam National University Medical School, and College of AI Convergence

• 08

  Selected for Korea Drug Development Fund 3rd Project. Ministry of Health and Welfare

• 07

  Selected for Vaccine Technology Commercialization Open Innovation Lab Project. Ministry of Health and Welfare

• 06

  Selected for Korea Drug Development Fund 2nd Project. Ministry of Health and Welfare

• 05

  Series B Bridge Investment (4.0 M USD)

• 03

  Signed Contract for CDMO (SAM)

2021

• 08

  Approval for Phase 1 Clinical Trials (¹⁸F-FDS)
  Preparation for Phase 1 Clinical Trials (¹⁸F-DMPY2)

• 07

  Selected for KARA Project (Korea Association for Radiation Application). Ministry of Science and ICT (1.5 M USD)

• 06

  Selected for KITIA Project (Korea Core Industrial Technology Investment Association). Ministry of Trade, Industry and Energy
  (2.0 M USD)

• 05

  Establishment of AI Convergence Research Center

• 04

  IND Process (¹⁸F-FDS, ¹⁸F-DMPY2)

• 02

  Series A Investment (6.0 M USD)
  Under CMC Process (SAM-01)

2020

• 10

  Selected as Bio-Healthcare Startup
  (Technology Commercialization Support Project)

• 06

  Selected for Pre-clinical Development Project. Ministry of SMEs and Startups (¹⁸F-DMPY2)
  Pre-clinical Study (¹⁸F-DMPY2)

• 04

  Certification of Affiliated Research Institute

2019

• 12

  Seed Investment (2.0 M USD)

• 09

  Certification of Venture Business

• 08

  CNCure Biotech, Inc. Founded on 29 August